Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone for LH Surge Prevention in PCOS
NCT06608186Phase 2Completed
- Start
- Oct 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of drospirenone in polycystic ovary syndrome (PCOS). Started Oct 2024; status: completed.
02
Drugs
drospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06608186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608186.